In the last trading session, 1.35 million Astrazeneca plc ADR (NASDAQ:AZN) shares changed hands as the company’s beta touched 0.47. With the company’s per share price at $79.24 changed hands at $0.57 or 0.72% during last session, the market valuation stood at $245.67B. AZN’s last price was a discount, traded about -10.65% off its 52-week high of $87.68. The share price had its 52-week low at $60.47, which suggests the last value was 23.69% up since then. When we look at Astrazeneca plc ADR’s average trading volume, we note the 10-day average is 3.75 million shares, with the 3-month average coming to 4.48 million.
Analysts gave the Astrazeneca plc ADR (AZN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.83. If we narrow down to specifics, the data shows that 0 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended AZN as a Hold, 8 felt it is a Buy and 0 rated the stock as Underweight. Astrazeneca plc ADR’s EPS for the current quarter is expected to be 1.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Astrazeneca plc ADR (NASDAQ:AZN) trade information
Instantly AZN was in green as seen at the end of in last trading. With action 2.19%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 17.65%, with the 5-day performance at 2.19% in the green. However, in the 30-day time frame, Astrazeneca plc ADR (NASDAQ:AZN) is -7.57% down. Looking at the short shares, we see there were 6.45 million shares sold at short interest cover period of 1.87 days.
The consensus price target for the stock as assigned by Wall Street analysts is 85, meaning bulls need an upside of 6.78% from its current market value. According to analyst projections, AZN’s forecast low is 79 with 89 as the target high. To hit the forecast high, the stock’s price needs a -12.32% plunge from its current level, while the stock would need to tank 0.3% for it to hit the projected low.
Astrazeneca plc ADR (AZN) estimates and forecasts
Data shows that the Astrazeneca plc ADR share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 18.60% over the past 6 months, a 11.85% in annual growth rate that is considerably higher than the industry average of 6.20%. Year-over-year growth is forecast to reach 14.10% up from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 13.13B. 4 analysts are of the opinion that Astrazeneca plc ADR’s revenue for the current quarter will be 13.73B. The company’s revenue for the corresponding quarters a year ago was 11.55B and 12.02B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 13.70%. The estimates for the next quarter sales put growth at 14.20%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.72%. The 2024 estimates are for Astrazeneca plc ADR earnings to increase by 12.98%, but the outlook for the next 5-year period is at 13.10% per year.
AZN Dividends
Astrazeneca plc ADR is expected to release its next quarterly earnings report on 2024-Nov-12. The 1.87% annual yield figure for the share gives it an annual dividend of 1.49. It is important to note, however, that the 1.87% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 2.37 per year.
Astrazeneca plc ADR (NASDAQ:AZN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.01% of Astrazeneca plc ADR shares while 17.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 17.03%. There are 17.03% institutions holding the Astrazeneca plc ADR stock share, with PRICE T ROWE ASSOCIATES INC /MD/ the top institutional holder. As of 2024-06-30, the company held 2.0962% of the shares, roughly 64.94 million AZN shares worth $5.06 billion.
PRIMECAP MANAGEMENT CO/CA/ holds the second largest percentage of outstanding shares, with 1.375% or 42.6 million shares worth $3.32 billion as of 2024-06-30.
